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Toll-like receptor agonist lipopeptides
self-assemble into distinct nanostructures†
Ian W. Hamley,*a Steven Kirkham,a Ashkan Dehsorkhi,a Valeria Castelletto,b
Mehedi Rezac and Janne Ruokolainenc
The self-assembled structure of toll-like receptor agonist lipopep-
tides containing the CSK4 peptide sequence is examined in aqueous
solution. A remarkable dependence of morphology on the number
of attached hexadecyl lipid chains is demonstrated, with spherical
micelle structures for mono- and di-lipidated structures observed,
but flexible wormlike micelles for the homologue containing three
lipid chains. The distinct modes of assembly may have an important
influence on the bioactivity of this class of lipopeptide.
Toll-like receptors (TLRs) are involved in the front line of the
innate immune response.1 They are a class of cell surface
receptors, found in many organisms. It is now established that
TLR2 mediates the cellular response to bacterial lipoproteins.2
Immune therapy adjuvants may be targeted to stimulate TLRs.3
Compared to other TLRs, TLR2 appears to mediate a broader
range of response to a variety of microbes.4 A lipoprotein
component of the cell wall of E. coli was identified in 1975,5
and this led to the development of synthetic TLR2 agonist
lipopeptides.
Lipopeptides N-acetylated via glycerol-linked cysteines show
activity against TLRs in particular TLR2, an observation that
has led to the development of commercially available molecules
including PAMCSK4, PAM2CSK4, or PAM3CSK4 containing
diﬀerent numbers of hexadecyl (palmitoyl, PAM) chains linked
to the glycerol unit linking the peptide CSKKKK (Fig. 1). The
dipalmitoyl lipopeptide PAM2CSK4 also shows agonist activity
against TLR2.6
To our knowledge, the self-assembly of this class of
commercially-available lipopeptide has not previously been
examined. Here we use the powerful combination of small-
angle X-ray scattering (SAXS) and cryogenic-transmission elec-
tron microscopy (cryo-TEM) to determine the self-assembled
nanostructure for the three lipopeptides PAMCSK4, PAM2CSK4
and PAM3CSK4. In addition, the secondary structure is probed
via UV circular dichroism spectroscopy. Remarkable diﬀer-
ences in the self-assembly behaviour are observed between
the three compounds, in particular PAMCSK4 and PAM2CSK4
form spherical micelles whereas PAM3CSK4 forms wormlike
micelles. These unprecedented observations may shed light on
the distinct bioactivity of these compounds. Studies show that
human TLR types discriminate between diﬀerent lipopeptide
structures including these three compounds.4 In particular,
PAM3CSK4 preferentially stimulates response to human TLR1
and TLR6, whereas TLR2 and TLR6 respond to PAM2CSK4. A
lipopeptide incorporating a cytotoxic T-cell epitope has been
shown to self-assemble into fibrils, and this lipopeptide
induces an immune response (mouse tumor model) in vivo.7
This occurred despite the absence of TLR2 activation.
PAM2CSK4 and PAM3CSK4 have been used as components
within synthetic virus like-particules used in vaccine delivery.
Each of the two lipopeptides were linked to a T-helper epitope
via a leucine zipper peptide.8 The influence of the aggregation
Fig. 1 Molecular structures of (a) PAMCSK4 and (b) PAM2CSK4 and (c)
PAM3CSK4.
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state of the CSK4-based lipopeptides on bioactivity has yet to
be elucidated, mainly because the aggregation state has not
been investigated to our knowledge. This is the focus of the
present study.
We first determined the critical aggregation concentration
(cac) for the three lipopeptides using the pyrene fluorescence
technique, widely used for other amphiphilic molecules9 and
more recently for lipopeptides.10 The concentration-dependent
intensity of the I1 vibronic band of the pyrene fluorescence at
373 nm is shown in Fig. 2. The cacs are determined by the
number of lipid chains, having the following values: PAM3CSK4
(cac = 0.003 wt%), PAM2CSK4 (cac = 0.035 wt%) and PAMCSK4
(cac = 0.12 wt%).
The secondary structure of the peptides within our CSK4
lipopeptide solutions was examined by CD spectroscopy
(Fig. 3a). All spectra, and other characterization data presented
in this paper, were measured for solutions of the three lipopeptides
at 0.5 wt% in LAL (limulus amebocyte lysate) water, as used in
bacterial endotoxin assays.
The CD spectra for PAMCSK4 and PAM2CSK4 show a mini-
mum below 200 nm consistent with a disordered conformation.
In complete contrast, the spectrum for PAM3CSK4 shows clear
features associated with b-sheet secondary structure,11 i.e. a
positive maximum near 200 nm and a negative minimum at
217 nm.
The self-assembly of the three lipopeptides was examined
using a combination of electron microscopy and small-angle
X-ray scattering (SAXS) techniques. Cryo-TEM reveals the
presence of spherical micelles in the solutions of PAMCSK4
and PAM2CSK4 (Fig. 4). These have a diameter of approxi-
mately 5 nm. Unexpectedly, and in complete contrast,
PAM3CSK4 forms worm-like micelles coexisting with globular
micelles (Fig. 4c). The wormlike micelles are notably flexible
and have a well defined width, in contrast to the highly extended
nanotapes/nanobelts observed for other lipopeptides,10d, f,g,12
which are also polydisperse in width as a result of a two-
dimensional self-assembly process.
SAXS provides support to the findings from cryo-TEM
regarding self-assembled nanostructure, and it enables more
detail to be obtained on the average dimensions and internal
structure of the micellar assemblies. As shown in Fig. 3b, the
SAXS profiles measured for the three lipopeptides in dilute
solution can be fitted to model form factors for spherical
micelles in the case of PAMCSK4 and PAM2CSK4 and for a
bilayer structure in the case of PAM3CSK4. The corresponding
parameters are listed in Table S1 (ESI†). The external radii of
the spherical micelles of PAMCSK4 and PAM2CSK4 are consis-
tent with TEM. A bilayer thickness of 5.3 nm is obtained from
the SAXS form factor fit for PAM3CSK4. The molecular length,
Fig. 2 Concentration dependence of pyrene fluorescence at 373 nm (I1)
for the three lipopeptides. The intersections of the lines shown define the
critical aggregation concentrations (cacs).
Fig. 3 (a) CD data. (b) SAXS data with form factor models described in text
for (a) PAMCSK4, (b) PAM2CSK4, (c) PAM3CSK4. The open symbols are the
experimental data, the solid red lines are the model form factor fits
described in the text (parameters in Table S1, ESI†). Curves are oﬀset for
convenience, and only every 5th data point is shown.
Fig. 4 Cryo-TEM images. (a) PAMCSK, (b) PAM2CSK4, (c) PAM3CSK4.
Enlarged images are shown at top in (a, b) and to the right in (c).
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considering the length of a hexadecyl lipid chain (ca. 1.6 nm)
together with the b-sheet forming hexapeptide headgroup
(6  0.33 nm (ref. 13) = 2 nm) is estimated to be around
3.6 nm. Therefore the observed 5.3 nm thickness indicates
interdigitation of the lipid chains, as observed for other
lipopeptides.10d, f,g
As PAM3CSK4 is typically provided commercially as the
hydrochloride whereas PAMCSK4 and PAM2CSK4 are provided
as TFA salts, we also checked whether the nature of the salt has
any eﬀect on PAM3CSK4 self-assembly. No significant influence
was revealed by cryo-TEM or SAXS. Fig. S1 (ESI†) shows a cryo-
TEM image for custom-synthesized PAM3CSK4(TFA) which
shows the same morphology of wormlike micelles shown in
Fig. 1c. Similarly, the SAXS profiles for PAM3CSK4 TFA and HCl
salts are almost identical (Fig. S2, ESI†) and the data can be
fitted using similar models.
A schematic for the proposed self-assembled structures is
shown in Fig. 5. PAMCSK4 and PAM2CSK4 clearly form small
spherical micelles, as shown by cryo-TEM and SAXS. The radius
of the micelles is consistent with packing of lipopeptides
lacking defined secondary structure, consistent with CD. The
radius of the micelles determined from SAXS for PAM2CSK4
(3.3 nm) is larger than that for PAMCSK4 (2.2 nm) as expected
given the larger volume occupied by the diacyl lipid chains in
the former system. All the lipopeptides contain the same
peptide with a highly charged tetra-lysine sequence which is
sequestered at the surface of the self-assembled nanostruc-
tures, this being separated from the lipid core by the CS
dipeptide spacer. Distinct from the mono- and di-lipid chain
molecules, PAM3CSK4 forms wormlike micelles. In contrast to
the extended and rigid nanotapes typically observed for other
lipopeptides,10d,f,g,12 the self-assemblies of PAM3CSK4, shown
by SAXS to contain a bilayer stacking of lipopeptides, resemble
more flexible wormlike micelles. Wormlike micelles are not
commonly observed for lipopeptides, although they have been
reported for a lipopeptide comprising a single palmitoyl chain
and the synthetic peptide sequence WAAAAKAAAAKAAAAKA.14
Based on the cryo-TEM observation of wormlike micelles for
PAM3CSK4, combined with SAXS showing a bilayer structure
and CD which shows b-sheet structure, we propose the self-
assembled structure shown in Fig. 5c, i.e. flattened wormlike
micelles with a bilayer packing of the lipopeptide molecules
packed into a b-sheet structure. We presume that the three lipid
chains in PAM3CSK4 cannot be accommodated into spherical
micelles, and that flattened or ellipsoidal wormlike micelles
result from these packing constraints. Our model is consistent
with the narrow width distribution for the wormlike micelles
notable in the cryo-TEM images, in contrast to the broad
distribution of widths observed for typical lipopeptide
nanotapes.
To investigate the thermal stability of the secondary struc-
tures, and the possible role of lipid chain melting, we per-
formed temperature-dependent CD measurements. The results
are shown in Fig. 6. Neither PAMCSK4 nor PAM2CSK4 show any
significant change in the disordered conformation in the
temperature range 20–60 1C which covers palmitoyl lipid chain
melting temperatures, i.e. the lipid chain melting transition
previously observed for palmitoyl lipopeptides.12c In contrast,
PAM3CSK4 exhibits a clear discontinuity in spectra between
30 1C and 40 1C, from a b-sheet conformation at lower tem-
perature to disordered at high temperature. This transition is
partially reversible. We associate this transition with the lipid
chain melting transition within the tri-palmitoyl chain lipopeptide.
The transition from the lipid gel to sol state (at around 40 1C)
has previously been shown to change the nanostructure of
self-assemblies (twisted ribbons or tapes) of gemini C16 surfac-
tants.15 In the case of PAM3CSK4 the lipid chain melting
may drive a morphological transition. This is currently under
further investigation.
Our findings concerning the distinct modes of self-assembly
of this class of lipopeptide depending on the number of lipid
chains may relate to the bioactivity of these compounds. To our
knowledge, the interaction of these lipopeptides with diﬀerent
toll-like receptors has not been correlated to self-assembled
nanostructure. Our results should stimulate further eﬀorts to under-
stand whether, and if so by what mechanism, self-assembled
Fig. 5 Model for self-assembled structures of (a) PAMCSK4, (b) PAM2CSK4,
(c) PAM3CSK4.
Fig. 6 Temperature dependent CD spectra for (a) PAMCSK4, (b) PAM2CSK4,
(c) PAM3CSK4.
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lipopeptide nanostructures interact with toll-like receptors. Also of
future interest is the ability to exploit the presence of a cysteine
residue in the linker peptide sequence to prepare cross-linked
lipopeptide nanostructures.
This work was supported by EPSRC grants EP/G067538/1
and EP/L020599/1 to IWH.
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